Farida Latif

Active 1990–2019

90
Papers
21,072
Citations
82
h-index
89
i10-index

Citations

Citations per year for Farida Latif1991: 5 citations1992: 9 citations1993: 22 citations1994: 52 citations1995: 111 citations1996: 130 citations1997: 185 citations1998: 154 citations1999: 152 citations2000: 149 citations2001: 216 citations2002: 323 citations2003: 311 citations2004: 267 citations2005: 324 citations2006: 217 citations2007: 293 citations2008: 192 citations2009: 223 citations2010: 194 citations2011: 223 citations2012: 192 citations2013: 150 citations2014: 182 citations2015: 127 citations2016: 166 citations2017: 105 citations2018: 93 citations2019: 414 citations2020: 312 citations2021: 260 citations2022: 187 citations2023: 122 citations2024: 164 citations2025: 52 citations2026: 2 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,083 citing papers, 33.6% of this breakdownUnited Kingdom: 521 citing papers, 8.4% of this breakdownChina: 483 citing papers, 7.8% of this breakdownGermany: 375 citing papers, 6.1% of this breakdownJapan: 251 citing papers, 4.1% of this breakdownFrance: 244 citing papers, 4% of this breakdownItaly: 213 citing papers, 3.4% of this breakdownCanada: 205 citing papers, 3.3% of this breakdownNetherlands: 192 citing papers, 3.1% of this breakdownAustralia: 157 citing papers, 2.5% of this breakdownSpain: 130 citing papers, 2.1% of this breakdownSwitzerland: 104 citing papers, 1.7% of this breakdown
0%33.6%Other 19.9%

Fields

  • Biochemistry, Genetics and Molecular Biology60.8%
  • Medicine31.5%
  • Neuroscience5.2%
  • Immunology and Microbiology1%
  • Agricultural and Biological Sciences0.3%
  • Computer Science0.2%
  • Other1%

Topics

  • Epigenetics and DNA Methylation8.9%
  • Cancer, Hypoxia, and Metabolism6.8%
  • RNA modifications and cancer4%
  • Renal cell carcinoma treatment4%
  • Cancer-related gene regulation3.3%
  • Renal and related cancers3%
  • Other70%

Coauthors

All papers

Open in search
  1. Identification of the von Hippel-Lindau Disease Tumor Suppressor Gene

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , W. Marston Linehan, Berton Zbar, Michael I. Lerman - Science 1993 cited by 3,015

  2. Mutations of the VHL tumour suppressor gene in renal carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Genetics 1994 cited by 1,741

  3. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1994 cited by 1,542

  4. Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma

    Authors: , , , , , , , , , - The American Journal of Human Genetics 2001 cited by 1,095

  5. NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Linda Holmfeldt, Charles G. Mullighan, Monique L. den Boer, Rob Pieters, Sima Jeha, Thomas L. Dunwell, Farida Latif, Deepa Bhojwani, William L. Carroll, Ching‐Hon Pui, R Myers, R. Kiplin Guy, Thirumala‐Devi Kanneganti, Mary V. Relling, William E. Evans - Nature Genetics 2015 cited by 160

  6. Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression

    Authors: , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2001 cited by 771

  7. Germline mutations in DIS3L2 cause the Perlman syndrome of overgrowth and Wilms tumor susceptibility

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Genetics 2012 cited by 252

  8. DNA methylation profiles of long- and short-term glioblastoma survivors

    Authors: , , , , , , , , , - Epigenetics 2013 cited by 134

  9. Functional Properties of a New Voltage-dependent Calcium Channel α2δ Auxiliary Subunit Gene (CACNA2D2)

    Authors: , , , , , , , , , , , - Journal of Biological Chemistry 2000 cited by 192

  10. The GALNT9, BNC1 and CCDC8 genes are frequently epigenetically dysregulated in breast tumours that metastasise to the brain

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Clinical Epigenetics 2015 cited by 110

  11. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.

    Authors: , , , , , , , , , , , , , - 2000 cited by 406

  12. Germline SDHB Mutations and Familial Renal Cell Carcinoma

    Authors: , , , , , , - JNCI Journal of the National Cancer Institute 2008 cited by 339

  13. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.

    Authors: , , , , , , - 2002 cited by 219

  14. Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma

    Authors: , , , , , , , , , , , , - Oncogene 2010 cited by 197

  15. A Role for the RASSF1A Tumor Suppressor in the Regulation of Tubulin Polymerization and Genomic Stability

    Authors: , , , , , , - Cancer Research 2004 cited by 157

  16. The epigenetic landscape of renal cancer

    Authors: , - Nature Reviews Nephrology 2016 cited by 145

  17. Role of the Ras-Association Domain Family 1 Tumor Suppressor Gene in Human Cancers

    Authors: , , - Cancer Research 2005 cited by 391

  18. Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns.

    Authors: , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1996 cited by 236

  19. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect

    Authors: , , , , , , , , , - Human Genetics 1995 cited by 181

  20. WFS1/wolframin mutations, Wolfram syndrome, and associated diseases

    Authors: , , , - Human Mutation 2001 cited by 175

  21. Genome-Wide DNA Methylation Profiling of CpG Islands in Breast Cancer Identifies Novel Genes Associated with Tumorigenicity

    Authors: , , , , , , , - Cancer Research 2011 cited by 163

  22. Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours

    Authors: , , , , , , , , , , , , , - Human Genetics 1994 cited by 150

  23. Molecular and cellular characterization of human renal cell carcinoma cell lines.

    Authors: , , , , , , , - 1992 cited by 110

  24. Slit-2 Induces a Tumor-suppressive Effect by Regulating β-Catenin in Breast Cancer Cells

    Authors: , , , , - Journal of Biological Chemistry 2008 cited by 99